Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8785433 | Brachytherapy | 2018 | 6 Pages |
Abstract
The D2cc is robust as evident by the low IOV (<5%). However, some variability ranges almost overlap with the clinical threshold level, which may present dosimetric and clinical complications. General rectal contouring guidelines for prostate high-dose-rate brachytherapy are desirable to reduce discrepancies in delineation.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Rodolfo Chicas-Sett, Francisco Celada-Alvarez, Susana Roldan, Silvia Rodriguez-Villalba, Miguel Santos-Olias, Pablo Soler-Catalan, Blanca Ibanez-Rosello, Leoncio Arribas, Alejandro Tormo, Jose M. Benlloch, Jose Perez-Calatayud,